This inventor holds 1 USPTO granted patent. Top assignee: Alusuisse Holdings A.g.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Introduction
Michael Alan Boss, an accomplished inventor based in Ruislip, Great Britain, has made significant contributions to the field of biotechnology. With one patent to his name, Boss has developed a transformative approach to myeloma cell-lines that enhances the expression of eukaryotic polypeptides, showcasing the intersection of innovation and practical application in medical science.
Latest Patents
His noteworthy patent, titled "Transformed Myeloma Cell-Line and a Process for the Expression of a Gene," reveals a myeloma cell-line transformed with a vector that includes a gene coding for a eukaryotic polypeptide, paired with a non-immunoglobulin promoter. This groundbreaking work employs various promoters, including viral options like the SV40 promoter, the Rous sarcoma virus long terminal repeat, or the Moloney murine leukemia long terminal repeat, as well as non-viral promoters such as the mouse metallothionein promoter. The application of this technology is exemplified in the production of tissue plasminogen activator (tPA) using host myeloma cell-lines, such as the rat YB/2/3.0 Ag20 hybridoma, the mouse SP-20 Ag hybridoma, and the mouse NSO hybridoma.
Career Highlights
Michael Alan Boss works at Alusuisse Holdings AG, a company recognized for its contributions to innovative materials and biotechnology. His expertise in myeloma cell-line technology reflects the commitment of the organization to advance scientific research and practical applications in the biotechnology sector.
Collaborations
Throughout his career, Boss has collaborated with John Henry Kenten, sharing insights and expertise to enhance their research outcomes. Together, they contribute to the ongoing advancements in biotechnology and the impact of their work on developing therapeutic solutions.
Conclusion
Michael Alan Boss represents the spirit of innovation within the biotechnology field. His patent for transforming myeloma cell-lines facilitates significant advancements in the expression of essential genes, thereby opening new avenues for therapeutic applications. Through his work at Alusuisse Holdings AG and collaboration with peers like John Henry Kenten, Boss continues to influence the future of biotech research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile